Bitrobius Genetics

Bitrobius Genetics is a UK biotech developing a novel DNA-based gene therapy platform technology designed to deliver functional copies of mutated genes to cells within a target tissue or organ.

Its platform is based on the principle of DNA replication and intercellular transmission, aiming to achieve broad tissue coverage from a single delivery event.

It is targeting genetic diseases affecting musculoskeletal and metabolic systems.